Coya Therapeutics, Inc. (COYA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $43.03M | +8.7% |
| 2024 | $39.58M | +11.1% |
| 2023 | $35.64M | +524.6% |
| 2022 | -$8.39M | -330.4% |
| 2021 | $3.64M | -56.1% |
| 2020 | $8.30M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $43.03M | +8.7% |
| 2024 | $39.58M | +11.1% |
| 2023 | $35.64M | +524.6% |
| 2022 | -$8.39M | -330.4% |
| 2021 | $3.64M | -56.1% |
| 2020 | $8.30M | — |